Health Catalyst Inc
NASDAQ:HCAT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.48
11.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Health Catalyst Inc
Wall Street
Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT
is 11.86 USD
with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
HCAT Last Price Targets
Health Catalyst Inc
The latest public price target was made on Sep 3, 2024 by
Richard Close
from
Canaccord Genuity
,
who expects
HCAT
stock to
rise by 55%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Richard Close
Canaccord Genuity
|
11
USD
Upside 55% |
3 months ago
Sep 3, 2024
|
Canaccord Genuity Reiterates Buy Rating on Health Catalyst Inc. (HCAT)
StreetInsider
|
Jessica Tassan
Piper Sandler
|
11
USD
Upside 55% |
3 months ago
Aug 26, 2024
|
Health Catalyst Inc. (HCAT) PT Lowered to $11 at Piper Sandler
StreetInsider
|
|
Jeff Garro
Stephens
|
7
USD
Downside 1% |
4 months ago
Aug 8, 2024
|
Health Catalyst Inc. (HCAT) PT Lowered to $7 at Stephens
StreetInsider
|
|
Jessica Tassan
Piper Sandler
|
14
USD
Upside 97% |
6 months ago
Jun 6, 2024
|
Health Catalyst Inc. (HCAT) PT Lowered to $14 at Piper Sandler
StreetInsider
|
Jack Wallace
Guggenheim
|
14
USD
Upside 97% |
10 months ago
Jan 26, 2024
|
Guggenheim Upgrades Health Catalyst Inc. (HCAT) to Buy
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCAT's stock price target?
Price Target
11.86
USD
According to Wall Street analysts, the average 1-year price target for
HCAT
is 11.86 USD
with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
What is Health Catalyst Inc's Revenue forecast?
Projected CAGR
10%
For the last 5 years the
compound annual growth rate for
Health Catalyst Inc's revenue is
21%.
The projected
CAGR
for the next 3 years is
10%.
You don't have any saved screeners yet
